Hipotensil

Hipotensil is an oral prescription medication that contains the active ingredient Captopril, an angiotensin‑converting enzyme (ACE) inhibitor. It is marketed in the European Union and is used under medical supervision to manage conditions related to elevated blood pressure and heart function. The product is formulated for systemic absorption after swallowing.

Hipotensil is indicated for several cardiovascular and renal conditions where blood pressure control is essential.

- Management of hypertension (high blood pressure). - Treatment of chronic heart failure to improve symptoms and reduce hospitalizations. - Adjunct therapy for diabetic nephropathy to slow kidney damage. - Post‑myocardial infarction therapy to improve survival. - Use in combination with other antihypertensive agents when monotherapy is insufficient.

Captopril may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common: - Dry cough. - Taste disturbances (metallic or salty taste). - Mild dizziness or light‑headedness. - Headache. - Nausea or mild gastrointestinal upset. - Rash or mild skin irritation.

Serious: - Angioedema affecting face, lips, tongue, or airway. - Persistent hypotension. - Acute kidney injury or worsening renal function. - Severe neutropenia or agranulocytosis. - Hepatotoxicity with elevated liver enzymes.

Before initiating Hipotensil, certain health considerations should be reviewed.

- Assess renal function; dose adjustment may be required in impaired kidneys. - Monitor serum potassium and electrolytes, especially when combined with potassium‑sparing diuretics. - Caution in patients with a history of angioedema or hereditary angioedema. - Use carefully in pregnancy; ACE inhibitors are generally contraindicated in the second and third trimesters. - Evaluate for possible interactions with non‑steroidal anti‑inflammatory drugs (NSAIDs) that may affect kidney function. - Regular blood pressure monitoring is essential to avoid excessive hypotension.

Captopril can interact with several drug classes, influencing its efficacy and safety.

Avoid: - Potassium supplements or potassium‑sparing diuretics (e.g., spironolactone) due to risk of hyperkalaemia. - Non‑selective NSAIDs that may reduce antihypertensive effect and impair renal function. - Lithium, as ACE inhibition can increase lithium levels and toxicity. - Dual ACE inhibitor or ARB therapy, which raises the risk of renal impairment and hyperkalaemia.

Use with caution: - Diuretics, especially thiazides, which may cause an initial drop in blood pressure. - Antidiabetic agents, as improved renal perfusion can alter glucose control. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole) that affect potassium balance. - Antihypertensive agents from other classes, requiring close blood pressure monitoring.